Carbapenem-resistant Klebsiella pneumoniae bacteremia: Factors correlated with clinical and microbiologic outcomes

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 2, 2010, Pages 180-184

  Nguyen, May ^a   Eschenauer, Gregory A ^b   Bryan, Monique ^a   O'Neil, Kelly ^a   Furuya, E Yoko ^a   Della Latta, Phyllis ^a   Kubin, Christine J ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Carbapenem; Klebsiella; Polymyxin; Tigecycline

Indexed keywords

CARBAPENEM; LEVOFLOXACIN; POLYMYXIN B; TIGECYCLINE; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPTIC SHOCK; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; CARBAPENEMS; COHORT STUDIES; FEMALE; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 77952745422     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.02.001     Document Type: Article

References (12)

1. Bradford P.A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., Rahal J.J., Brooks S., Cebular S., Quale J. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin. Infect. Dis. 2004, 39:55-60.
2. Bratu S., Landman D., Haag R., Recco R., Eramo A., Alam M., Quale J. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 2005, 165:1430-1435.
3. Bratu S., Mooty M., Nichani S., Landman D., Gullans C., Pettinato B., Karumudi U., Tolaney P., Quale J. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 2005, 49:3018-3020.
4. Bratu S., Tolaney P., Karumudi U., Quale J., Mooty M., Nichani S., Landman D. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J. Antimicrob. Chemother. 2005, 56:128-132.
5. Gootz T.D., Lescoe M.K., Dib-Hajj F., Dougherty B.A., He W., Della-Latta P., Huard R.C. Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob. Agents Chemother. 2009, 53:1998-2004.
6. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 1995, 13:818-829.
7. Munoz-Price L.S., Zembower T., Schreckenberger P., Harton L., Mohapatra S., Baig M.O., Lee-Such S.C., Leong L., Lolans K., Lavin M.A., Welbel S., Maio-Hillegonds S., Weinstein R.A., Quinn J.P. Tigecycline (tg) vs. colistin (co) for the treatment of multidrug resistant (mdr) Acinetobacter baumannii (ab) blood stream infection (bsi). Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL 2007, American Society for Microbiology, Washington, DC, USA, Abstract K-389.
8. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 2009, 9:228-236.
9. Patel G., Huprikar S., Factor S.H., Jenkins S.G., Calfee D.P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control. Hosp. Epidemiol. 2008, 29:1099-1106.
10. Peleg A.Y., Potoski B.A., Rea R., Adams J., Sethi J., Capitano B., Husain S., Kwak E.J., Bhat S.V., Paterson D.L. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J. Antimicrob. Chemother. 2007, 59:128-131.
11. Thom K.A., Shardell M.D., Osih R.B., Schweizer M.L., Furuno J.P., Perencevich E.N., McGregor J.C., Harris A.D. Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points. Infect. Control. Hosp. Epidemiol. 2008, 29:1048-1053.
12. Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., Alberti S., Bush K., Tenover F.C. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2001, 45:1151-1161.